The search for a cancer vaccine has largely been a painstaking, systematic chore of isolating some agent that might produce cancer-killing antibodies in human patients.
“Paralyzed people fooled by a Super Bowl ad showing Christopher Reeve walking have been calling an advocacy group to find out how he was cured.” –Associated Press, Feb. 1, 2000 I have long been reluctant to criticize Christopher Reeve.
A 92-year-old woman with cocaine strapped to her body flew all the way from Brazil to Spain before police arrested her, in a wheelchair, at Madrid’s airport.
An experimental vaccine for cocaine addicts can help some users kick the habit, according to a new study. Researchers at Yale School of Medicine have tested a vaccine that makes people produce antibodies to cocaine
When Tyra Smith’s boyfriend, Chris Lewis, first suggested they be guinea pigs in a H1N1 vaccination study in August, she wasn’t so crazy about the idea.
A strong earthquake rocked Bhutan on Monday, blocking access roads in the mountainous Asian kingdom and killing at least five people, the country’s home minister told CNN.
As December storms paint Bryce Canyon National Park with fresh snow, you won’t find a more beautiful winter landscape anywhere in the world. The university’s Center for Vaccine Development has received more than 500 responses from potential volunteers since Wednesday, when the National Institutes of Health (NIH) announced human trials for a swine flu vaccine would begin in early August.
What if science made a pill to protect us from addiction keeping us from smoking cigarettes, getting fat or abusing drugs and alcohol? According to encouraging results from several lines of study, it seems that day may be closer than we thought. Researchers in labs around the world are now developing vaccines to inoculate people against dangerously addictive substances such as cocaine, heroin and methamphetamine.
In February 1976, an outbreak of swine flu struck Fort Dix Army base in New Jersey, killing a 19-year-old private and infecting hundreds of soldiers. Concerned that the U.S
Terminal lung cancer patients are living longer thanks to the world’s first registered lung cancer vaccine, a leading Cuban scientist says. Dr. Gisela Gonzalez has spent years researching the vaccine which the Cuban government approved for the use of the general public last year.